Belgrade to Host the Anniversary Biotech Forum AI 4 LIFE

The Office for Information Technologies and eGovernment of the Government of the Republic of Serbia announced today that Belgrade will host the fifth, anniversary edition of the international conference AI 4 LIFE: Biotech Future Forum on 29 and 30 October, where the latest developments in biotechnology, medicine and artificial intelligence will be presented.

 
 

On this occasion, leading scientists from around the world, industry representatives, investors, innovators and policymakers will gather at Ložionica. Among the distinguished guests will be Gregg Semenza, the 2019 Nobel Prize laureate in Physiology or Medicine and a professor at Johns Hopkins University.

Belgrade will also welcome Molly Stevens from the University of Oxford, Andrea Califano from Columbia University, Marietta Jiménez from Merck Healthcare, and Dragomir Milovanović from Charité – Universitätsmedizin Berlin.

The programme will focus on next-generation therapies, the application of artificial intelligence in the life sciences, bioelectronic medicine, nanotechnology and innovation financing. Particular emphasis will be placed on the development of AI infrastructure, advanced chips and achievements in the pharmaceutical industry.

The conference is organised by the Government of the Republic of Serbia and the Centre for the Fourth Industrial Revolution in Serbia, in cooperation with the Office for Information Technologies and eGovernment, the World Economic Forum and the United Nations Development Programme (UNDP), with the support of the BIO4 Campus.

Further information about the programme, speakers and registration is available at the following link.

Over its first four years, the Forum has developed into a recognised international platform connecting science, technology, public policy and business.

Source: srbija.gov.rs

Newsletter

For more information about news in terms of innovation, please subscribe to our Newsletter.

You have successfully been subscribed.

You are already subscribed.

You cannot subscribe to this newsletter.